Multi_CycGT: a DL-based multimodal model for membrane permeability prediction of cyclic peptides
暂无分享,去创建一个
Silong Zhai | Xinyi Wu | Chengyun Zhang | H. Duan | Yejian Wu | Lujing Cao | Zhenyu Xu | Tianfeng Shang | Liefeng Ma
[1] Y. Akiyama,et al. CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides , 2023, J. Chem. Inf. Model..
[2] Matthew R. Naylor,et al. Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides , 2023, Nature Communications.
[3] T. Le,et al. Membrane Permeating Macrocycles: Design Guidelines from Machine Learning , 2022, J. Chem. Inf. Model..
[4] Shiyu Chen,et al. Cyclic peptide drugs approved in the last two decades (2001–2021) , 2021, RSC chemical biology.
[5] G. Caron,et al. Permeability prediction in the beyond-Rule-of 5 chemical space: focus on cyclic hexapeptides. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] Zewen Li,et al. A Survey of Convolutional Neural Networks: Analysis, Applications, and Prospects , 2020, IEEE Transactions on Neural Networks and Learning Systems.
[7] Xuechen Li,et al. Ligation Technologies for the Synthesis of Cyclic Peptides. , 2019, Chemical reviews.
[8] Yang Jiang,et al. Macrocyclic peptides as regulators of protein-protein interactions , 2018, Chinese Chemical Letters.
[9] Jolene L. Lau,et al. Therapeutic peptides: Historical perspectives, current development trends, and future directions. , 2017, Bioorganic & medicinal chemistry.
[10] Lukasz Kaiser,et al. Attention is All you Need , 2017, NIPS.
[11] Ulf Norinder,et al. Structural and conformational determinants of macrocycle cell permeability. , 2016, Nature chemical biology.
[12] Max Welling,et al. Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.
[13] Alun Jones,et al. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides , 2015, Chembiochem : a European journal of chemical biology.
[14] D. Murray,et al. Romidepsin targets multiple survival signaling pathways in malignant T cells , 2015, Blood Cancer Journal.
[15] Matthew P. Jacobson,et al. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products. , 2015, Future medicinal chemistry.
[16] Spiros Liras,et al. Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability. , 2015, European journal of medicinal chemistry.
[17] Yizhong Zhang,et al. Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance(). , 2012, MedChemComm.
[18] Cristiano Ruch Werneck Guimarães,et al. Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation , 2012, J. Chem. Inf. Model..
[19] D. Craik,et al. Discovery and applications of naturally occurring cyclic peptides. , 2012, Drug discovery today. Technologies.
[20] Christopher J. White,et al. Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.
[21] H. Kessler,et al. N‐Methylation of Peptides: A New Perspective in Medicinal Chemistry , 2009 .
[22] Stephen P. Hale,et al. The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.
[23] Horst Kessler,et al. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. , 2008, Angewandte Chemie.
[24] Matthew P Jacobson,et al. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.
[25] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[26] Yoshua Bengio,et al. Convolutional networks for images, speech, and time series , 1998 .
[27] S. Hochreiter,et al. Long Short-Term Memory , 1997, Neural Computation.
[28] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[29] T. Hoffmann,et al. Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.
[30] Peter E. Hart,et al. Nearest neighbor pattern classification , 1967, IEEE Trans. Inf. Theory.